United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Sales | 437 |
| Cost of Goods | 164 |
| Gross Profit | 272 |
| Operating Expenses | 35,857 |
| Operating Income | -35,421 |
| Interest Expense | 58 |
| Other Income | 1,975 |
| Pre-tax Income | -33,503 |
| Income Tax | 4 |
| Net Income Continuous | -33,507 |
| Net Income | $-33,507 |
| EPS Basic Total Ops | -1.26 |
| EPS Basic Continuous Ops | -1.25 |
| EPS Diluted Total Ops | -1.26 |
| EPS Diluted Continuous Ops | -1.25 |
| EBITDA(a) | $-36,672 |